PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $51.00 to $62.00. They now have an "overweight" rating on the stock.
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $55.00 price target on the stock, up previously from $41.00.MarketBeat
- PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $70.00 price target on the stock, up previously from $67.00.MarketBeat
- PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $55.00 price target on the stock.MarketBeat
- $5.2 Bn Duchenne Muscular Dystrophy Market Opportunity Analysis and Forecasts, 2023-2024 & 2025-2033: Focus on US, France, Germany, Italy, Spain, UK, Japan [Yahoo! Finance]Yahoo! Finance
- We Might See A Profit From PTC Therapeutics, Inc. (NASDAQ:PTCT) Soon [Yahoo! Finance]Yahoo! Finance
PTCT
Earnings
- 2/27/25 - Beat
PTCT
Sec Filings
- 3/12/25 - Form 4
- 3/12/25 - Form 144
- 3/11/25 - Form 144
- PTCT's page on the SEC website